Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q3 2018 (← Previous) (Next →)
Filing Date: Nov 14, 2018
Total Value: $1.138B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARRAY BIOPHARMA INC | 6,290,586 | $95.62M | 8.4% | — | — | COM | 04269X105 |
| — | CHEMOCENTRYX INC | 6,773,760 | $85.62M | 7.5% | — | — | COM | 16383L106 |
| — | MERUS N V | 3,914,913 | $77.28M | 6.8% | — | — | COM | N5749R100 |
| CYTK | CYTOKINETICS INC | 5,186,839 | $51.09M | 4.5% | — | — | COM NEW | 23282W605 |
| — | FIVE PRIME THERAPEUTICS INC | 3,381,117 | $47.06M | 4.1% | — | — | COM | 33830X104 |
| — | BLUEPRINT MEDICINES CORP | 598,267 | $46.7M | 4.1% | — | — | COM | 09627Y109 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 15,232,268 | $41.28M | 3.6% | — | — | COM | 45665G303 |
| KURA | KURA ONCOLOGY INC | 2,015,856 | $35.28M | 3.1% | — | — | COM | 50127T109 |
| — | MIRATI THERAPEUTICS INC | 723,322 | $34.07M | 3.0% | — | — | COM | 60468T105 |
| — | ARQULE INC | 5,827,902 | $32.99M | 2.9% | — | — | COM | 04269E107 |
| XNCR | XENCOR INC | 837,538 | $32.64M | 2.9% | — | — | COM | 98401F105 |
| — | PIERIS PHARMACEUTICALS INC | 5,600,521 | $31.36M | 2.8% | — | — | COM | 720795103 |
| — | BIOLINERX LTD | 25,995,575 | $27.82M | 2.4% | — | — | SPONSORED ADR | 09071M106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 2,617,967 | $26.94M | 2.4% | — | — | COM | 74366E102 |
| IONS | IONIS PHARMACEUTICALS INC | 520,000 | $26.82M | 2.4% | — | — | COM | 462222100 |
| XOMA | XOMA CORP DEL | 1,502,800 | $26.4M | 2.3% | — | — | COM NEW | 98419J206 |
| ANAB | ANAPTYSBIO INC | 250,265 | $24.97M | 2.2% | — | — | COM | 032724106 |
| — | GALMED PHARMACEUTICALS LTD | 1,761,567 | $23.92M | 2.1% | — | — | SHS | M47238106 |
| — | CONCERT PHARMACEUTICALS INC | 1,592,138 | $23.63M | 2.1% | — | — | COM | 206022105 |
| — | FORWARD PHARMA A/S | 8,502,925 | $19.39M | 1.7% | — | — | SPONSORED ADR | 34986J105 |
| — | DICERNA PHARMACEUTICALS INC | 1,152,073 | $17.58M | 1.5% | — | — | COM | 253031108 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,890,507 | $16.22M | 1.4% | — | — | COM | 221015100 |
| ACIU | AC IMMUNE SA | 2,017,500 | $16.14M | 1.4% | — | — | SHS | H00263105 |
| — | IMMUNE DESIGN CORP | 4,658,353 | $16.07M | 1.4% | — | — | COM | 45252L103 |
| SPRO | SPERO THERAPEUTICS INC | 1,488,088 | $15.64M | 1.4% | — | — | COM | 84833T103 |
| XENE | XENON PHARMACEUTICALS INC | 1,165,553 | $15.38M | 1.4% | — | — | COM | 98420N105 |
| — | MOLECULAR TEMPLATES INC | 2,787,629 | $15.03M | 1.3% | — | — | COM | 608550109 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $14.97M | 1.3% | — | — | COM NEW | 12648L601 |
| RCUS | ARCUS BIOSCIENCES INC | 1,058,840 | $14.76M | 1.3% | — | — | COM | 03969F109 |
| REPL | REPLIMUNE GROUP INC | 911,852 | $14.68M | 1.3% | — | — | COM | 76029N106 |
| — | VERASTEM INC | 1,986,994 | $14.41M | 1.3% | — | — | COM | 92337C104 |
| KALV | KALVISTA PHARMACEUTICALS INC | 609,014 | $13.46M | 1.2% | — | — | COM | 483497103 |
| — | CALITHERA BIOSCIENCES INC | 2,544,000 | $13.36M | 1.2% | — | — | COM | 13089P101 |
| — | MEI PHARMA INC | 3,080,308 | $13.28M | 1.2% | — | — | COM NEW | 55279B202 |
| — | SPRING BK PHARMACEUTICALS INC | 953,301 | $11.49M | 1.0% | — | — | COM | 849431101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,233,618 | $9.968M | 0.9% | — | — | COM | 87164F105 |
| — | ONCOMED PHARMACEUTICALS INC | 4,042,989 | $8.571M | 0.8% | — | — | COM | 68234X102 |
| — | CIDARA THERAPEUTICS INC | 1,930,670 | $8.495M | 0.7% | — | — | COM | 171757107 |
| — | VBI VACCINES INC | 3,100,000 | $7.502M | 0.7% | — | — | COM NEW | 91822J103 |
| — | ALBIREO PHARMA INC | 218,800 | $7.212M | 0.6% | — | — | COM | 01345P106 |
| — | CONTRAFECT CORP | 3,478,326 | $7.2M | 0.6% | — | — | COM | 212326102 |
| — | PRINCIPIA BIOPHARMA INC | 240,000 | $7.013M | 0.6% | — | — | COM | 74257L108 |
| — | MERRIMACK PHARMACEUTICALS INC | 1,110,588 | $5.919M | 0.5% | — | — | COM NEW | 590328209 |
| ARGX | ARGENX SE | 76,808 | $5.825M | 0.5% | — | — | SPONSORED ADR | 04016X101 |
| — | TESARO INC | 140,000 | $5.461M | 0.5% | — | — | COM | 881569107 |
| — | ERYTECH PHARMA | 625,000 | $5.45M | 0.5% | — | — | SPONSORED ADR | 29604W108 |
| — | GENOCEA BIOSCIENCES INC | 5,265,000 | $4.105M | 0.4% | — | — | COM | 372427104 |
| — | ALPINE IMMUNE SCIENCES INC | 643,059 | $4.071M | 0.4% | — | — | COM | 02083G100 |
| — | SURFACE ONCOLOGY INC | 360,218 | $3.941M | 0.3% | — | — | COM | 86877M209 |
| — | SUNESIS PHARMACEUTICALS INC | 1,684,636 | $3.369M | 0.3% | — | — | COM PAR | 867328700 |
| — | REGULUS THERAPEUTICS INC | 13,685,204 | $2.704M | 0.2% | — | — | COM | 75915K101 |
| — | ADURO BIOTECH INC | 287,776 | $2.115M | 0.2% | — | — | COM | 00739L101 |
| — | VICAL INC | 1,332,605 | $1.826M | 0.2% | — | — | COM NEW | 925602203 |
| — | ESSA PHARMA INC | 576,771 | $1.731M | 0.2% | — | — | COM NEW | 29668H708 |
| — | REALM THERAPEUTICS PLC | 360,866 | $1.173M | 0.1% | — | — | SPONSORED ADS | 75606L103 |
| — | LOXO ONCOLOGY INC | 4,089 | $699K | 0.1% | — | — | COM | 548862101 |
| — | ZYMEWORKS INC | 19,804 | $311K | 0.0% | — | — | COM | 98985W102 |